Argent Biopharma (AU:RGT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent Biopharma Limited has announced its application for quotation of 2.5 million ordinary fully paid securities on the ASX under the code RGT. The announcement, dated July 17, 2024, indicates the company’s expansion in the stock market. Investors may watch this development closely as it signifies Argent’s growth trajectory.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.